Categories
Tags
Abbott Advertising AstraZeneca Barack Obama Biotechnology and Pharmaceuticals Breast cancer Bristol Myers Squibb business Cancer Clinical trial Conditions and Diseases Deal Eli Lilly European Commission European Union FDA Food and Drug Administration Genentech generics GlaxoSmithKline Google GSK HBA Health Health care Johnson & Johnson layoffs Lilly Margaret Hamburg Marketing Merck Novartis Pfizer Pharma Pharmaceutical drug pharmaceutical industry Research and development Roche Sanofi-Aventis Schering Plough social media Twitter U.S. Food and Drug Administration United States Wyeth
Technology News
BioPharm News- Shire Gains European Approval for its Gaucher Disease Treatment
- Mtech Bioprocess Scale-Up Facility to Double in Staff and Size
- ImClone Closes Plant in New Jersey, Consolidating Erbitux Manufacture
- EMA and FDA Seek Applicants for Joint GMP Inspections
- ATMI Expands Bloomington, Minnesota Manufacturing Facility
Clinical Trials News- CRF Health Achieves EXACT ePRO Vendor Certification for Windows Mobile Systems
- ACR Image Metrix Establishes Global Presence
- BioPharm Systems Named to the 2010 Inc. 500|5000 List of Fastest-Growing Companies in the U.S.
- CRF Health Doubles North American Headquarters
- Oracle Completes Acquisition of Phase Forward
Blogroll
-
Meta
Tag Archives: layoffs
AstraZeneca to Slash 8,000 More Jobs (Updated 2/3/10)
Last year, AstraZeneca announced the elimination of some 15,000 jobs. Last Thursday, the London-based company revealed that it plans to lay off another 8,000 by 2014—this despite global revenue growth of 4 percent for 2009.
Much of the drive for this addition labor sculpting stems from AZ’s desire to streamline its R&D; the company will focus [...]
Posted in Strategy Also tagged AstraZeneca, business, Company, David Brennan, Employment, GlaxoSmithKline, London, Research and development 1 Comment
Cold Cuts: Merck Layoffs Loom
Image via Wikipedia
It is not just cold outside these days, as Merck & Co. makes some cold hard decisions. Following on the heels of its now closed acquisition of Schering-Plough, Merck is making significant job cuts across its operations. Some 16,000 jobs are expected to be eliminated in total as a result of the merger.
According [...]
AstraZeneca, BMS Announce Layoffs and Buyouts
AstraZeneca was the topic of conversation this week as word broke that the company is offering buyout deals to every member of its 5,500 US sales force.
“AstraZeneca is making changes to our sales force, which will be managed first by looking at vacancies and offering field sales employees the opportunity to self-identify whether they are [...]
Posted in Strategy Also tagged AstraZeneca, Bristol Myers Squibb, Buyouts, Indiana, New York City, Pfizer, Strategy, Wyeth 1 Comment
Pharma Layoffs Continue
It’s been another tough few weeks for pharma employees as four more companies handed out pink slips in an effort to trim bottom lines.
Elan cut 14 percent of its global work force last Wednesday as a part of an ongoing strategic review process. The company announced that it would postpone biologics manufacturing, redesign R&D in [...]

Pfizer NYC Tower Up For Sale